Solutions
Who it's for
Therapeutic areas
Platform updates, partnerships, regulatory milestones, and clinical evidence.
2026-05-28
Vitruvian Shield has completed an independent expert review by a clinical key opinion leader through Instituto Pedro Nunes under the IPN healthproof framework. The review, finalised on 28 May 2026 as a 14-page report version Final v1.0, concludes that the platform is clinically valuable and strategically promising for decentralised and hybrid clinical research. It is an expert opinion, not a study result.
